Tissue versus mechanical mitral valve replacement in patients aged 50–70: a propensity-matched analysis
Survival following mechanical and bioprosthetic MVR in patients 50-70 years of age is similar to up to 15 years of follow-up. Bioprosthetic MVR is associated with an increased risk of repeat MVR. Mechanical MVR is not associated with an increased risk of stroke. Valve selection in this patient population requires diligent consideration of structural valve deterioration and subsequent reoperation risk as well as bleeding and thromboembolic risk.
Authors
- Jimmy J.H. Kang (ORCID: https://orcid.org/0000-0002-3351-2593)
- Ryaan EL‐Andari (ORCID: https://orcid.org/0000-0001-7146-4337)
- Abeline R. Watkins
- Jeevan Nagendran (ORCID: https://orcid.org/0000-0002-2050-6717)
- Nicholas M. Fialka (ORCID: https://orcid.org/0000-0002-7277-6188)
- Abrar S. Alam (ORCID: https://orcid.org/0000-0001-9768-2455)
- Michael C. Moon (ORCID: https://orcid.org/0000-0001-6617-8336)
- Sabin J. Bozso (ORCID: https://orcid.org/0000-0001-7067-3102)
- Yongzhe Hong (ORCID: https://orcid.org/0000-0003-0232-2014)
Institutions
- Valve (United States) (US)
- University of Alberta (CA)
Publication Details
- Journal
- European Journal of Cardio-Thoracic Surgery
- Published
- 2024-08-01
- DOI
- https://doi.org/10.1093/ejcts/ezae283
- Citations
- 3
- Primary Topic
- Cardiac Valve Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.21